Oxeia Biopharmaceuticals, Inc.

CIK 1610315 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Oxeia Biopharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026C/A0001610315-26-000014
Jul 21, 2026C/A0001610315-26-000011
May 26, 2026C/A0001610315-26-000010
Apr 3, 2026C/A0001610315-26-000008
Apr 2, 2026C/A0001610315-26-000007
Jan 15, 2026C/A0001610315-26-000005
Jan 5, 2026C0001610315-26-000002
Jun 8, 2022RW0001493152-22-016130
May 3, 2022FWP0001493152-22-011918
Apr 14, 2022S-10001493152-22-009970
Jun 16, 2014D0000897069-14-000300